Company Filing History:
3 out of 277 
2 out of 2,077 
Years Active: 2022-2025
Title: The Innovations of John Palma: A Glimpse into His Contributions in Oncology
Introduction
John Palma, based in Alamo, California, is a notable inventor with a robust portfolio of five patents, showcasing his innovative contributions to the field of oncology. His work primarily focuses on improving treatment methodologies for patients suffering from Acute Myeloid Leukemia (AML) and colorectal cancer.
Latest Patents
Among his latest patents, Palma has developed a method for determining AML response to treatment with farnesyltransferase inhibitors. This novel method provides a rapid and accurate identification of AML patients, especially benefiting the elderly demographic. By utilizing whole blood instead of traditional bone marrow samples, his technique enhances the accuracy and reduces the invasiveness and costs of the assay. The method particularly evaluates a two-gene expression ratio (RASGRP1:APTX), which enables precise predictions of treatment responses. Furthermore, his research suggests that elderly AML patients identified as likely responsive can achieve recovery rates comparable to younger patients receiving the best available therapies.
Another significant patent is a method that predicts treatment response in colorectal cancer patients by measuring tumor genetic heterogeneity through an analysis of circulating tumor DNA. This innovative approach aims to provide a more personalized treatment strategy based on genetic insights.
Career Highlights
Throughout his career, John Palma has collaborated with renowned institutions such as Roche Sequencing Solutions, Inc. and Janssen Pharmaceutica NV. His experience in these reputable companies has allowed him to develop groundbreaking methodologies in cancer treatment.
Collaborations
Palma has worked alongside notable colleagues like John Lee and Tatiana I. Vener. These collaborations have further enhanced his research capabilities and have contributed to the successful development of his innovative patents.
Conclusion
John Palma exemplifies the spirit of innovation in the medical field, particularly in oncology. His patents reflect a commitment to improving patient care through less intrusive and more accurate diagnostic methods, paving the way for better therapeutic approaches. With his ongoing work, Palma continues to inspire advancements in cancer treatment and research.